---
title: "Atenolol - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db00335-mesh-d006973-1.html
toc: false 
---


Path ID: `DB00335_MESH_D006973_1`
{% include image.html url="images/db00335-mesh-d006973-1.png" file="db00335-mesh-d006973-1.png" alt="db00335-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001262 | Atenolol | Drug |
| UniProt:P08588 | Beta-1 adrenergic receptor | Protein |
| UniProt:P00797 | Renin | Protein |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Atenolol | DECREASES ACTIVITY OF | Beta-1 Adrenergic Receptor |
| Beta-1 Adrenergic Receptor | POSITIVELY REGULATES | Renin |
| Beta-1 Adrenergic Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Renin | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | AFFECTS RISK FOR | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00335](https://go.drugbank.com/drugs/DB00335)
  - [https://en.wikipedia.org/wiki/Atenolol](https://en.wikipedia.org/wiki/Atenolol)
